Merck's updated data on its #Molnupiravir pill against #COVID19 has shown to be 30 per cent less effective in reducing the risk of hospitalisation and deaths than an earlier interim analysis. pic.twitter.com/gbkU7r5vY4— IANS Tweets (@ians_india) November 27, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


